AU5415699A - Water-soluble pharmaceutical formulation for administering sildenafil - Google Patents

Water-soluble pharmaceutical formulation for administering sildenafil

Info

Publication number: AU5415699A
Authority: AU; Australia
Prior art keywords: water; pharmaceutical formulation; soluble pharmaceutical; sildenafil; administering
Prior art date: 1998-07-31
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU54156/99A

Inventor

Thomas Strungmann

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Hexal AG

Original Assignee

Hexal AG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-07-31

Filing date

1999-07-30

Publication date

2000-02-28

1999-07-30 Application filed by Hexal AG filed Critical Hexal AG

2000-02-28 Publication of AU5415699A publication Critical patent/AU5415699A/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Gynecology & Obstetrics (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicinal Preparation (AREA)

AU54156/99A 1998-07-31 1999-07-30 Water-soluble pharmaceutical formulation for administering sildenafil Abandoned AU5415699A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE19834507A DE19834507A1 (en)	1998-07-31	1998-07-31	Pharmaceutical, water-soluble tablet formulation for the use of sildenafil
DE19834507		1998-07-31
PCT/EP1999/005464 WO2000007596A1 (en)	1998-07-31	1999-07-30	Water-soluble pharmaceutical formulation for administering sildenafil

Publications (1)

Publication Number	Publication Date
AU5415699A true AU5415699A (en)	2000-02-28

Family

ID=7875941

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU54156/99A Abandoned AU5415699A (en)	1998-07-31	1999-07-30	Water-soluble pharmaceutical formulation for administering sildenafil

Country Status (3)

Country	Link
AU (1)	AU5415699A (en)
DE (1)	DE19834507A1 (en)
WO (1)	WO2000007596A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0015239D0 (en) *	2000-06-21	2000-08-16	Biochemie Gmbh	Organic compounds
BRPI0003386B8 (en)	2000-08-08	2021-05-25	Cristalia Produtos Quim Farmaceuticos Ltda	homo- or heterodimeric prodrugs useful in treating diseases or disorders mediated by phosphodiesterases; pharmaceutical compositions containing the prodrug or its pharmaceutical acceptable salts; process of obtaining these prodrugs
EP1469852A4 (en) *	2002-01-04	2009-12-02	Ford Henry Health System	DONORS OF NITROGEN MONOXIDE FOR THE TREATMENT OF DISEASES AND INJURIES
KR100435514B1 (en) *	2002-03-22	2004-06-10	한미약품 주식회사	Fast dissolving formulation of sildenafil lactate
GB0219516D0 (en) *	2002-08-21	2002-10-02	Phoqus Ltd	Fast dissolving and taste masked oral dosage form comprising sildenafil
GB0606234D0 (en) *	2006-03-29	2006-05-10	Pliva Istrazivanje I Razvoj D	Pharmaceutically acceptable salts and polymorphic forms
FR3013221B1 (en) *	2013-11-19	2020-11-27	Nabil Said	EFFERVESCENT PHARMACEUTICAL COMPOSITION BASED ON SILDENAFIL AND ITS MANUFACTURING PROCESS

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9013750D0 (en) *	1990-06-20	1990-08-08	Pfizer Ltd	Therapeutic agents
CA2277017C (en) *	1997-01-06	2002-11-26	Pfizer Inc.	Rapidly releasing and taste-masking pharmaceutical dosage form
JPH10298062A (en) *	1997-04-24	1998-11-10	Pfizer Pharmaceut Co Ltd	Oral fast dissolving tablets
BR9809848A (en) *	1997-05-19	2000-06-27	Zonagen Inc	Composition
DK1035833T3 (en) *	1997-12-02	2006-01-09	Archimedes Dev Ltd	Composition for nasal administration
GB9726343D0 (en) *	1997-12-13	1998-02-11	Auffret Anthony	The use of excipients to accelerate freeze-drying
TW542719B (en) *	1998-02-23	2003-07-21	Pfizer Res & Dev	Method of treating impotence due to spinal cord injury

1998
- 1998-07-31 DE DE19834507A patent/DE19834507A1/en not_active Withdrawn
1999
- 1999-07-30 AU AU54156/99A patent/AU5415699A/en not_active Abandoned
- 1999-07-30 WO PCT/EP1999/005464 patent/WO2000007596A1/en not_active Ceased

Also Published As

Publication number	Publication date
WO2000007596A1 (en)	2000-02-17
DE19834507A1 (en)	2000-02-03

Publication	Publication Date	Title
AU2331801A (en)	2001-07-09	Improved pharmaceutical compositions for poorly soluble drugs
PL351526A1 (en)	2003-05-05	Pharmaceutical formulation comprising amoxycillin
AU7375598A (en)	1998-11-27	Stable oral pharmaceutical dosage forms
PL343491A1 (en)	2001-08-27	Pharmaceutical aerosol formulation
AU1267400A (en)	2000-05-29	Pharmaceutical moxifloxacin preparation
AU1827799A (en)	1999-07-05	Oral delivery formulation
AU4328800A (en)	2000-11-10	Pharmaceutical formulation
AU2001284444A1 (en)	2002-06-13	Preparations for oral administration
AU6715600A (en)	2001-03-19	Pharmaceutical formulations
AU1304601A (en)	2001-06-06	Solid preparations for oral use
AU5838398A (en)	1998-09-17	Rapamycin formulations for oral administration
AU2564399A (en)	1999-08-16	Isoflavanoid formulations for oral administration
AU4977300A (en)	2000-11-17	Pharmaceutical formulations
AU5415699A (en)	2000-02-28	Water-soluble pharmaceutical formulation for administering sildenafil
AU1385801A (en)	2001-04-30	Pharmaceutical formulations
AU3055099A (en)	1999-12-06	A pharmaceutical formulation for nasal administration
AU5072000A (en)	2000-12-28	Pharmaceutical composition for nasally administering water-soluble active substances
AU1688099A (en)	2000-07-31	Pharmaceutical preparation
AU3839900A (en)	2000-11-10	Pharmaceutical formulation
AU2870899A (en)	1999-09-15	Oral formulation for hydrophilic drugs
AU5182099A (en)	2000-03-06	Pharmaceutical formulation
AU6473699A (en)	2000-05-22	Aqueous drug formulation for oral application
AU1388501A (en)	2001-06-06	Pharmaceutical formulation
AU3860797A (en)	1999-02-10	Pharmaceutical formulations for oral administration
AU2279800A (en)	2000-06-13	Pharmaceutical preparation

Legal Events

Date	Code	Title	Description
2001-04-26	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase